Nitric oxide in the clinical arena
- 28 December 1991
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 338 (8782) , 1560-1562
- https://doi.org/10.1016/0140-6736(91)92378-f
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shockPublished by Elsevier ,2005
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionThe Lancet, 1991
- NG-Monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shockBiochemical and Biophysical Research Communications, 1991
- Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation, 1991
- Hyperdynamic circulation in cirrhosis: a role for nitric oxide?The Lancet, 1991
- Role of nitric oxide in maintaining vascular integrity in endotoxin‐induced acute intestinal damage in the ratBritish Journal of Pharmacology, 1990
- L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.Circulation Research, 1990
- Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivoEuropean Journal of Pharmacology, 1990
- NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.Proceedings of the National Academy of Sciences, 1990
- Nitric Oxide and Nitrogen Dioxide as Inducers of Acute Pulmonary Injury when Inhaled at Relatively High Concentrations for Brief PeriodsInhalation Toxicology, 1990